RecruitingPhase 4NCT05821972

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine for Cleft Palate

Nebulized Dexmedetomidine Combined With Ketamine Versus Nebulized Dexmedetomidine to Induce Preoperative Sedation and Attenuate Emergence Agitation in Children Undergoing Cleft Palate Repair Surgeries


Sponsor

Assiut University

Enrollment

60 participants

Start Date

Apr 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To compare the efficacy of the pre-operative nebulization of a combination of dexmedetomidine and ketamine versus nebulization of dexmedetomidine alone for sedation and prevention of emergence delirium in children undergoing cleft palate repair surgeries.


Eligibility

Min Age: 12 MonthsMax Age: 48 Months

Inclusion Criteria1

  • Patients with American Society of Anesthesiologists (ASA) physical status I \& II who will be scheduled for cleft palate repair surgeries

Exclusion Criteria6

  • Parent refusal
  • Allergy to the study drugs
  • Suspected difficult airway
  • Patients with endocrine, renal, hepatic, and cardiac pathology
  • Psychiatric diseases
  • Asthmatic patients.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGNebulization of dexmedetomidine and ketamine

Pre-operative nebulization of dexmedetomidine and ketamine

DRUGNebulization of dexmedetomidine

Pre-operative nebulization of dexmedetomidine


Locations(1)

Assiut University

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05821972


Related Trials